Live Quote · NASDAQSUPNHealthcare· Drug Manufacturers - Specialty & Generic

Supernus, Inc.

$29.04
MKT CAP $6.03B
50%
Bullish
TickerSpark Score
69/100
▌ Solid
76
Valuation
80
Profitability
70
Growth
50
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SUPN research report →

Analyst Price Target
$47.50+63.6% vs. today

Range $43 – $53

Analyst RatingBuy
10 Buy2 Hold0 Sell

Price Chart

-12.70% · this period
$42.76$34.46$26.16Nov 19May 22Nov 19